Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

U.S. multi-state cannabis producer Curaleaf Holdings Inc. CURLF, -0.24% on Wednesday said it will have to tweak its sales or sales forecasts for its fiscal 2021 and 2022, following a review of transactions made through its wholesale business and “additional material weaknesses” discovered in its accounting protocols. Management said it expects the restatement of the sales figures will lower 2021 sales by around 1.25%, and lower expected sales for 2022 by approximately 0.75%.

U.S. cannabis giant Curaleaf says it misstated revenue

Minor Reductions in Revenue of Approximately 1.25% and 0.75% for 2021 and 2022, respectively NEW YORK, April 19, 2023 /PRNewswire/ --  Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), announced today that the Audit Committee of the Company's Board of Directors (the "Audit Committee"), with the assistance of outside counsel and consultants and in discussion with the Company's auditors, has been conducting, after internal review by management,  a review of certain purchases and sales of products through the Company's wholesale channel to determine whether they had commercial substance, and to confirm the timing and appropriateness of the recognition of revenue from those transactions, mainly in the last quarter of 2021 and the first and second quarters of 2022. Further to this review, the Company has determined that it will make certain adjustments to the revenue figures reported in its previously issued (i) audited annual consolidated financial statements for the fiscal year ended December 31, 2021 (the "2021 Annual Financial Statements") and (ii) unaudited interim consolidated financial statements for the first, second and third quarters of the fiscal year ended December 31, 2022 (collectively, the "2022 Interim Financial Statements"), as well as other related flow through adjustments.

Curaleaf to Restate Certain Previously Issued 2022 and 2021 Financial Statements

Curaleaf's recreational license renewal in New Jersey, a reversal of the state's Cannabis Regulatory Commission's (CRC's) earlier decision, is a positive development for the company according to Stifel GMP analysts.   “As a result, we no longer intend to revise our forecasts based on this past week's events and will wait for 4Q FY22 results to update our outlook, with a focus on gaining greater clarity on management's industry-high guidance of greater than $125 million 2023 free cash flow,” the analysts wrote in a note to clients.

Curaleaf's recreational license renewal in New Jersey ‘positive,' analysts say

Aurora Cannabis

Cronos Group

Tilray Brands

Tomorrow, 'only' in states where it's legal, cannabis will be celebrated as part of the long-fabled 4/20 (April 20) holiday.

4 Cannabis Stocks to Watch Right Now

Curaleaf Holdings, Inc. guided to $125 million in free cash flow this year after exiting several tough state markets. The cannabis space remains a regulatory landmine with the license renewal drama in New Jersey.

Curaleaf: New Narrative Despite New Jersey Drama

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that today, Monday, April 17th, the Board of the New Jersey Cannabis Regulatory (CRC) reversed itself and voted to approve Curaleaf's adult use cannabis licenses.

NJ CRC Board Reverses Itself and Fully Approves Curaleaf's Adult Use License Renewals After Legal Challenge

Curaleaf Holdings Inc. CURLF, +4.35% CURA, +5.45% stock is up 4.2% after New Jersey Cannabis Regulatory Commission on Monday approved a renewal of the Massachusetts-based company's cultivation and retail licenses for adult-use in the Garden State, in a reversal of a decision last week, according to spokespeople for the commission and Curaleaf. The New Jersey Cannabis Control Commission met in an emergency session ahead of the expiration of Curaleaf's license later this week.

Curaleaf wins renewal for NJ licenses after emergency meeting of state's cannabis regulatory commission

Analysts at Canaccord Genuity (TSX:CF, LSE:CF) are not yet updating their estimates for Curaleaf as the cannabis producer appeals the New Jersey Cannabis Regulatory Commission's (CRC's) vote against renewing its adult-use retail and cultivation licenses in the state as of April 21, 2023. Curaleaf said in a statement on April 14 that it has fulfilled the requirements necessary for the renewal of its licenses, it has never received any violation notices from the CRC to allow it to remedy the concern, and it will work with the CRC to ensure the renewal of its licenses.

Curaleaf holds on to rating and price target as it appeals non-renewal of New Jersey licenses

The U.S.-listed shares of Curaleaf Holdings Inc. CURLF, -9.84% CURA, -9.25% tumbled 10.2% toward a record low in morning trading Friday, in the wake of the decision by the New Jersey Cannabis Regulatory Commission (CRC Board) to deny the renewal of the Massachusetts-based company's cultivation and retail licenses for adult use. “We believe the CRC Board has wrongly interpreted the applicable regulations and that its decision to retaliate against Curaleaf for our need to consolidate production into one local facility is lacking in merit,” said Curaleaf Chairman Boris Jordan.

Curaleaf stock tumbles toward record low after NJ denies license renewal, but analyst sees case for company to appeal and sue

NEW YORK , April 14, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today commented on yesterday's decision New Jersey Cannabis Regulatory Commission's Board (the "CRC Board") to deny Curaleaf, one of the largest operators in the State of New Jersey, a renewal of its cultivation and retail licenses for adult-use.

CURALEAF COMMENTS ON NEW JERSEY CANNABIS REGULATORY COMMISSION'S BOARD DECISION

NEW YORK, April 14, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of Curaleaf Boca Raton Glades, the company's 59th dispensary in Florida and 151st dispensary nationwide. Located at 7875 Glades Rd, Boca Raton, FL 33434, Curaleaf Boca Raton Glades is the first of two new locations to open in the Sunshine State this month. The company will open its 60th Florida dispensary, Curaleaf West Palm Beach, 300 Clematis St, West Palm Beach, FL 33401, by the end of the month pending regulatory approvals.

Curaleaf Continues Retail and Brand Expansions in Florida

Investors saw new lows for CURLF shares. Curaleaf delayed its Q4 earnings release and conference call. There are two big issues facing cannabis companies.

Curaleaf Stock: New Lows And A Cloudy Outlook

Transaction Bolsters Curaleaf's Presence in Utah as State's Largest Retail Operator

Curaleaf Completes Acquisition of Deseret Wellness

Bitfarms Ltd

Harmony Gold Mining Co Ltd

Polestar Automotive Holding UK PLC

Solid Power

Waterdrop

While some of the top penny stocks to buy carry risk, there are still plenty of opportunities to be found. In fact, today, my focus is on some thrilling penny stocks that investors may want to consider at current levels.

7 Thrilling Penny Stocks for Aggressive Investors to Buy

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Hirsh Jain and Jeffrey Schultz unpack the drama around New York and California's cannabis markets. Perceived vs actual opportunity, creating a *truly* equitable marketplace.

Unpacking New York And California Cannabis Markets

Canopy Growth

The marijuana industry could see significant growth as legalization progresses in the U.S. and around the world. The risk for investors is that U.S. federal legalization isn't a certainty.

The Best Growth Stocks Could Be in This Industry -- but There's a Catch

US Pot Stocks For April 2023 The post 3 Top US Marijuana Stocks To Watch In April 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Top US Marijuana Stocks To Watch In April 2023

Amplify Seymour Cannabis ETF

Greenrose Acquisition Corp

Innovative Industrial Properties

Amplify US Alternative Harvest ETF

MedMen Enterprises Inc.

Advisorshares Poseidon Dynamic Cannabis ETF

Roundhill Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Bengal Capital's Jerry Derevyanny moved away from top multi-state operators (MSOs) to find the most value. Why EBITDA falls short as a useful metric to measure cannabis stocks.

Where Is The Value In Cannabis Stocks?

Transaction Strengthens Curaleaf's Presence in Utah as State's Largest Retail Operator Upon Close, the Company's Retail Footprint Will Increase to Four Dispensaries in Utah and 150 Nationwide NEW YORK , March 29, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has entered into a definitive agreement to acquire Deseret Wellness ("Deseret"), the largest cannabis retail operator in Utah, in a cash and stock transaction valued at approximately US$20 million (the "Transaction"). The Transaction is expected to close imminently, subject to customary closing conditions.

Curaleaf Announces Acquisition of Deseret Wellness

Amplify Alternative Harvest ETF

SNDL Inc.

As the winds of change sweep across the U.S., the once-taboo cannabis sector is steadily gaining traction. With increasing acceptance from both regulators and consumers, the marijuana sphere has the potential to inject robust long-term growth into your investment portfolio — especially with this list of the best cannabis stocks to own.

The 7 Best Cannabis Stocks to Buy for Long-Term Growth

All-New, Flavor-Forward Jellies, Chocolates and Tarts Launching in Florida and Arizona With Additional States To Follow NEW YORK , March 27, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the expansion of its brand portfolio with the launch of JAMS, a flavor-forward cannabis edibles brand designed to meet the needs of new cannabis consumers and those seeking an introduction to edibles. JAMS is now available in Florida and is coming soon to Arizona with additional states to follow in the coming months.

Curaleaf Expands Brand Portfolio with Launch of JAMS™ Cannabis-Infused Edibles

HEXO Corp

High Tide

Jazz Pharmaceuticals

OrganiGram Holdings Inc.

This developing industry has ample opportunity and sustained tailwinds. Very few U.S. companies have positive operating margins; very few of their Canadian counterparts have positive gross margins.

Finding The Long-Term Winners In The Cannabis Sector

Are US pot stocks on your list for 2023? The post Top Marijuana Stocks To Buy In 2023? US MSOs On Watch appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Buy In 2023? US MSOs On Watch

The global banking turmoil threatens to squeeze U.S. cannabis companies already struggling with meager funding sources by drying up support from regional lenders and tightening fundraising from alternative avenues.

High & Dry: Banking crisis to further choke funding for cannabis sector

NEW YORK , March 24, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it will delay its fourth quarter and full year earnings release and conference call, which were originally scheduled for March 28, 2023. Due to the complexities of converting three years of financials from IFRS to U.S. GAAP coinciding with year and quarter-end reporting, and the review of the treatment of various accounting matters, the Company requires additional time to complete its financial statements.

Curaleaf Provides Update on 2022 Fourth Quarter and Full-Year Earnings Release and Earnings Call

News for Curaleaf Holdings, Inc. Stock (CURLF)